Jianbo Wu

3.1k citations
117 papers · 2.4k indexed · 1 hit paper · h-index 29
Topics
Angiogenesis and VEGF in Cancer (20 papers)MicroRNA in disease regulation (15 papers)Adipokines, Inflammation, and Metabolic Diseases (15 papers)
Journals
Journal of Biological ChemistrySHILAP Revista de lepidopterologíaPLoS ONE

In The Last Decade

Jianbo Wu

112 papers receiving 2.3k citations

Hit Papers

Removal of organic pollutants through hydroxyl radical-ba...202320262024202520234080120

Peers

Jianbo Wu
Comparison fields: 5 of 136
  • Molecular Biology 989
  • Cancer Research 481
  • Immunology 243
  • Epidemiology 236
  • Cardiology and Cardiovascular Medicine 231
Replace Sérgio Paulo Bydlowski with:
Sérgio Paulo Bydlowski Brazil
Junling Liu China
Christopher D. Kontos United States
Ruud D. Fontijn Netherlands
John J. Castellot United States
Xiaozhong Wang China
Vladimir V. Shuvaev United States
Hong Hong China
Nadira Yuldasheva United Kingdom
Feng Kong China
Jianbo Wu relative to Sérgio Paulo Bydlowski Brazil Sérgio Paulo Bydlowski's profile →
Citations per field
00.5×
Sérgio Paulo Bydlowski · 1×
Citations per year

Countries citing papers authored by Jianbo Wu

Since Specialization
Citations

This map shows the geographic impact of Jianbo Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianbo Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianbo Wu more than expected).

Fields of papers citing papers by Jianbo Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianbo Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianbo Wu. The network helps show where Jianbo Wu may publish in the future.

Co-authorship network of co-authors of Jianbo Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jianbo Wu. A scholar is included among the top collaborators of Jianbo Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianbo Wu. Jianbo Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 2
4 3
5 14
6 6
7 17
8 8
9 4
10
The Astragaloside IV Derivative LS-102 Ameliorates Obesity-Related Nephropathy
14
11 11
12 25
13 9
14 11
15 5
16 34
17 42
18
Complex agonist-like properties of ICI 182,780 (Faslodex) in human breast cancer cells that predominantly express progesterone receptor-B: implications for treatment resistance.
9
19 26
20 43

About Jianbo Wu

Jianbo Wu is a scholar working on Cancer Research, Immunology and Allergy and Hematology, having authored 117 papers that have together received 2.4k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (20 papers), MicroRNA in disease regulation (15 papers) and Adipokines, Inflammation, and Metabolic Diseases (15 papers). The work is most often cited by research in Cancer Research (481 citations), Internal Medicine (96 citations) and Immunology and Allergy (94 citations). Jianbo Wu has collaborated with scholars based in China, United States and Pakistan. Frequent co-authors include Mao Luo, Ni Chen, Salman M. Hyder, Meiping Ren, Youkun Zheng, Xin Deng, Liqun Wang, William P. Fay, Hui Jiang and Xuemei Wang. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026